Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Becton Dickinson and Co    BDX

Delayed Quote. Delayed  - 08/26 10:02:01 pm
175.47 USD   +0.76%
08/18 BECTON DICKINSO : BD Celebrates 60 Years In Sandy, Utah
08/16 BECTON DICKINSO : BD Cited As Infusion Pump EMR Integration Leader I..
08/16 BECTON DICKINSO : BD Receives FDA Clearance for New Syringe Designed..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Becton Dickinson's 1st-Quarter Earnings Surge; Raises Year-View

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/05/2013 | 12:50pm CEST
   By Saabira Chaudhuri 
 

Becton Dickinson & Co.'s (>> Becton, Dickinson and Co.) fiscal first-quarter earnings more than doubled as the medical device maker recorded revenue growth across all its segments, while margins also widened.

For the current year, Becton raised the bottom end of its revenue guidance, now expecting foreign currency neutral revenue growth starting at 4% versus its prior view starting at 3.5%. It now expects per-share earnings from continuing operations between $5.69 and $5.72, up from its prior view of earnings between $5.58 and $5.64.

The maker of products like surgical blades and test kits last spring struck a deal to sell the bulk of its lab-products business to Corning Inc. (>> Corning Incorporated) for $730 million in cash. Analysts who follow the company noted the sale stripped Becton Dickinson of a cash cow yet also gave it the freedom to focus on businesses with higher growth potential.

Ahead of the company's earnings announcement, analysts at Mizuho Securities downgraded Becton's ratings, noting that the company's life science research business--which makes up about 15% of sales--has been a drag on results for the past year, adding that they see no significant catalysts for the business in the near-term, as the academic market continues to be sluggish.

Still, Chief Executive Vincent A. Forlenza on Tuesday said the company is "starting to see notable results," adding that Becton is "growing revenues across our three segments, driving margin expansion and delivering a higher quality of earnings."

For the quarter ended Dec. 31, Becton Dickinson reported a profit of $625.4 million, or $3.13 a share, compared with $263 million, or $1.21 a share, a year earlier. Per-share earnings from continuing operations were $1.35 versus $1.14.

Revenue increased 3.7% to $1.9 billion. Analysts polled by Thomson Reuters most recently forecast earnings of $1.24 a share on revenue of $1.86 billion.

Gross margin widened to 52.9% from 50.8%.

Becton Dickinson's sales grew 3% in the U.S. and 4.3% internationally. The company's medical unit, its largest by revenue, reported sales rose 3.5%. The diagnostics business posted revenue growth 5%, while bioscience revenue was up 1.7%.

Shares closed Monday at $85.16 and were inactive premarket. The stock has risen 11% in the past three months.

Write to Saabira Chaudhuri at saabira.chaudhuri@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Becton, Dickinson and Co., Corning Incorporated
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BECTON DICKINSON AND CO
08/27 BECTON DICKINSON AND : Federal Contracts Awarded by Federal Agencies in Louisian..
08/27 BECTON DICKINSON AND : $264,705 Federal Contract Awarded to Becton, Dickinson & ..
08/25 BECTON DICKINSON AND : BD Cited As Infusion Pump EMR Integration Leader In KLAS ..
08/25 BECTON DICKINSON AND : Patent Issued for Internal Cam Metering Pump (USPTO 94167..
08/23 BECTON DICKINSON AND : MILITARY $75,500 Federal Contract Awarded to Becton, Dick..
08/18 BECTON DICKINSON AND : Trademark Application for "HEMOGARD" Filed
08/18 BECTON DICKINSON AND : Trademark Application for "BD FOX" Filed by Becton Dickin..
08/18 BECTON DICKINSON AND : BD Celebrates 60 Years In Sandy, Utah
08/16 BECTON DICKINSON AND : BD Cited As Infusion Pump EMR Integration Leader In KLAS ..
08/16 BECTON DICKINSON AND : BD Receives FDA Clearance for New Syringe Designed for th..
More news
Sector news : Medical Supplies
08/27 ABBOTT LABORATORIES : Whiplashed investors stay skittish about St. Jude
08/26DJST JUDE MEDICAL : . Jude Denies Report Its Heart Devices Are Vulnerable to Cyber..
08/26DJST JUDE MEDICAL : . Jude Denies Claims in Muddy Waters Report
08/26DJST JUDE MEDICAL : . Jude Denies Report Its Heart Devices Are Vulnerable to Cyber..
08/26 MUDDY WATERS SAYS ST. JUDE SHARES CO : Cnbc
More sector news : Medical Supplies
News from SeekingAlpha
08/25 88 Stock Picks For The Next 30 Years (Or More)
08/23 5 Buys From The Narrow-Moat Universe
08/21 MY PORTFOLIO UPDATE AND REVIEW OF 83 : Up 2 With Reynolds And Exelon, Down 1 Wit..
08/15 The 10 Best Dividend Aristocrats
08/11 The Sector Olympians
Advertisement
Financials ($)
Sales 2016 12 483 M
EBIT 2016 2 660 M
Net income 2016 1 343 M
Debt 2016 10 201 M
Yield 2016 1,50%
P/E ratio 2016 28,44
P/E ratio 2017 21,65
EV / Sales 2016 3,81x
EV / Sales 2017 3,74x
Capitalization 37 362 M
More Financials
Chart BECTON DICKINSON AND CO
Duration : Period :
Becton Dickinson and Co Technical Analysis Chart | BDX | US0758871091 | 4-Traders
Full-screen chart
Technical analysis trends BECTON DICKINSON ...
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 183 $
Spread / Average Target 4,4%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Vincent A. Forlenza Chairman, President & Chief Executive Officer
Christopher R. Reidy EVP, Chief Financial & Administrative Officer
Ellen R. Strahlman Chief Medical Officer, EVP-Research & Development
Bertram L. Scott Independent Director
Gary A. Mecklenburg Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BECTON DICKINSON AND C..13.88%37 362
TELEFLEX INCORPORATED38.75%8 032
SHANDONG WEIGAO GROUP ..-8.32%2 823
HARTALEGA HOLDINGS BER..--.--%1 792
TOP GLOVE CORPORATION ..--.--%1 320
HOGY MEDICAL CO., LTD.12.50%1 097
More Results